BioEngine Shines At BIOCHINA 2025: Leading Biopharmaceutical Innovation With Serum-Free Culture Media

BioEngine, as an advocate and practitioner of serum-free culture media, presented a variety of serum-free culture media at BIOCHINA2025 (held at Suzhou International Expo Centre on March 15), bringing professional and comprehensive cell culture solutions to the audience, and assisting the innovative development of the biopharmaceutical industry.

Popularity and eye-catching activities

The crowded booth attracted many industry colleagues to stop and communicate with each other. Whether it was the 'Dada password', technology sharing, or on-site research activities with prizes, all participants were enthusiastic, and the atmosphere was warm and extraordinary.

BioEngine's first live broadcast attracted hundreds of viewers online.During the live broadcast, BioEngine introduced its star product series of serum-free culture media to the audience in detail, fully demonstrating the company's innovative strength and product advantages in the field of biotechnology. In addition, the cute and funny Fatty made a surprise appearance and presented an energetic dance performance, which pushed the atmosphere of the site to a climax and attracted many participants to stop and watch.

Numerous products attracted attention

BioEngine presented a variety of serum-free culture media at the exhibition. BioEngine's many serum-free culture media products were highly regarded and recognised by both domestic and international customers due to their excellent performance and cost-effectiveness.

Continuous Innovation Enabling the Future

On 13th March, BioEngine was awarded the title of 'TOP 100 Supplier of the Year' in the BIOCHINA Awards 2024, the ninth annual BIOCHINA Awards. This honour is not only a high recognition of BioEngine, but also a full affirmation of its continuous innovation, high-quality service and leading position in the industry.

As a leader in serum-free culture media, BioEngine has always been committed to providing biopharmaceutical companies with international quality, cost-effective serum-free culture media and related cell culture technology services. To date, we have successfully served 400+ domestic and international customers in the antibody, vaccine and CGT biopharmaceutical fields. We are committed to becoming the most reliable cell culture partner in the world and continue to empower the innovation and upgrading of cell culture technology!